JULIE ESTEP: Open Payments
NPI 1366890626 · ASHLAND, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,647 in 92 payments from 9 companies in 2025. Trend: 2023 $1,097 · 2024 $1,612 · 2025 $1,647
Food & beverage: $1,647
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 41 | $694 |
| UCB, Inc. | 13 | $240 |
| Novartis Pharmaceuticals Corporation | 11 | $239 |
| AstraZeneca Pharmaceuticals LP | 11 | $182 |
| Janssen Biotech, Inc. | 4 | $77 |
| Amgen Inc. | 4 | $72 |
| PFIZER INC. | 3 | $62 |
| E.R. Squibb & Sons, L.L.C. | 3 | $53 |
| GlaxoSmithKline, LLC. | 2 | $28 |
Products named: SKYRIZI, Bimzelx, COSENTYX, SAPHNELO, TREMFYA, RINVOQ, XELJANZ, OTEZLA.
Industry payments across KY — which companies pay providers there.
